Stock UniverseDerived research view · source repositories remain read-only

uniQure N.V. (QURE)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Watch
Selection Score
31.69
Global Rank
1704
Market Cap
973.62M
Latest Close
26.45
RS Composite
29.21% · G#304

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
15.91%
3M
85.35%
6M
3.81%
1Y
76.80%
3Y
37.12%
5Y
-23.84%
10Y
95.28%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.45M · 30-day average: 1.97M · Max drawdown over stored range: -95.40%

Research Snapshot

Relative Strength vs SPX

RS Composite29.21%
20D RS8.89%
60D RS41.65%
120D RS26.93%
Global RS Rank304 · 90.94% percentile
Watch+Speculative RS Rank177 · 91.56% percentile
Group ScopeWatch+Speculative
Primary RS Rank49 · 89.30% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank207 / 701
Primary Percentile70.61
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-05n/an/a-191.74M-208.87M-3.50-300.20M965.00K-301.17M60Mn/an/an/an/an/a139.99M49.94M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-3.50-7.5xn/an/a$-5.05-5.2x$-5.04-5.3x

Shares Diluted: 60M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue37.514524.002106.48315.84327.11916.098
Revenue Growth (YoY)415.231%1296.817%-79.679%-85.122%71.173%-40.639%
Gross Profit-84.886362.161-85.637-194.566-132.8414.412
Operating Income-125.426311.701-134.645-264.427-182.071-185.349
Free Cash Flow-142.099270.521-162.748-153.083-186.096-178.402
Free Cash Flow Per Share-3.1965.775-3.482-3.211-3.825-3.1025318950268015
EPS (Diluted) GAAP-2.8116537.04-2.712932-6.47098-4.924158-3.46024
EPS Growth
EPS Non-GAAP
Gross Margin-226.278%69.114%-80.423%10400%10400%89.527%
Operating Margin-334.345%59.485%-126.447%-1669.046%-671.378%-1151.379%
Profit Margin-333.273%62.898%-119.07%-1947.093%-883.351%-1235.998%
Free Cash Flow Margin-378.789%51.626%-152.839%-966.25%-686.22%-1108.2246%
Shares Outstanding (Diluted)44.466446.84146.73547.67148.649157.5021
Shares Change (YoY)11.167%5.34%-0.226%2.003%2.052%18.198%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-053.56Mn/a-45.72M-12.84%-53.53M-15.03%-0.8562.74M139.99M49.94Mprocessed
2025 Q42026-03-02n/an/a-51.12Mn/a-37.09Mn/a-0.5962.37M80.24M49.70Mprocessed
2025 Q32025-11-10n/an/a-51.03Mn/a-80.53Mn/a-1.3858.52M597.06M51.88Mprocessed
2025 Q22025-07-29n/an/a-43.87Mn/a-37.72Mn/a-0.6954.81M253.78M51.84Mprocessed
2025 Q12025-05-09n/an/a-39.33Mn/an/an/a-0.8253.11M217.23M51.59Mprocessed
2024 Q42025-02-27n/an/a-45.83Mn/an/an/an/a48.87M158.93M51.32Mprocessed
2024 Q32024-11-05n/an/a-40.23Mn/an/an/a-0.9148.72M251.63M51.11Mprocessed
2024 Q22024-08-01n/an/a-44.01Mn/an/an/a-1.1648.62M287.88M102.51Mprocessed
2024 Q12024-05-07n/an/a-54.23Mn/an/an/a-1.3648.38M243.06M102.12Mprocessed
2023 Q42024-02-28n/an/a-61.75Mn/an/an/an/a47.82M241.36M101.75Mprocessed
2023 Q32023-11-07n/an/a-81.88Mn/an/an/a-1.8847.77M229.48M101.43Mprocessed
2023 Q22023-08-01n/an/a-65.07Mn/an/an/a-1.4447.65M513.60M101.11Mprocessed
2023 Q12023-05-09n/an/a-74.17Mn/an/an/a-1.6347.44M153.85M103.25Mprocessed
2022 Q42023-02-27n/an/a26.50Mn/an/an/an/a46.90M228.01M102.79Mprocessed
2022 Q32022-11-02n/an/a-59.52Mn/an/an/a-1.0246.77M440.31M102.39Mprocessed
2022 Q22022-08-08n/an/a-56.06Mn/an/an/a-0.8446.67M500.52M101.89Mprocessed
2022 Q12022-05-02n/an/a-54.08Mn/an/an/a-1.0046.60M524.89M101.42Mprocessed
2021 Q42022-02-25n/an/a2.07Mn/an/an/an/a47.02M556.26M100.96Mprocessed
2021 Q32021-10-25n/an/a-45.00Mn/an/an/a-0.7946.15M578.46M71.49Mprocessed
2021 Q22021-07-26n/an/a398.01Mn/an/an/a8.5146.93M677.33M70.78Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.